Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The PAIN Trial
NCT05972681Phase 4Terminated
- Sponsor
- Montefiore Medical Center
- Start
- Apr 2025
- Primary completion
- Oct 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine and epinephrine in Postpartum pain (PPP) (2 arms), sponsored by Montefiore Medical Center. Primary endpoints: Time to First Analgesic at 24 hours, Maternal Satisfaction at 7 days and 1 more. Started Apr 2025; status: terminated.
02
Drugs
bupivacaineepinephrine
03
Conditions
Postpartum pain (PPP)
Beyond the preview
Go deeper on NCT05972681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05972681.